These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
178 related items for PubMed ID: 3585612
1. Absorption characteristics of once-a-day slow-release theophylline preparation in children with asthma. Pedersen S, Steffensen G. J Pediatr; 1987 Jun; 110(6):953-9. PubMed ID: 3585612 [Abstract] [Full Text] [Related]
3. Steady-state evaluation of twice-a-day dosing of a new sustained-release theophylline preparation for young children. Welch MJ, Kemp JP, Orgel HA, Meltzer EO. J Asthma; 1985 Jun; 22(5):249-52. PubMed ID: 4055657 [Abstract] [Full Text] [Related]
4. Theophylline absorption in young asthmatic children receiving sustained-release formulations. Haltom JR, Szefler SJ. J Pediatr; 1985 Nov; 107(5):805-10. PubMed ID: 4056986 [Abstract] [Full Text] [Related]
6. Bioavailability of a slow-release theophylline capsule given twice daily to preschool children with chronic asthma: comparison with liquid theophylline. Sallent J, Hill M, Stecenko A, McKenzie M, Hendeles L. Pediatrics; 1988 Jan; 81(1):116-20. PubMed ID: 3336577 [Abstract] [Full Text] [Related]
16. Pharmacokinetics of a sustained-release theophylline preparation in infants and preschool children with asthma. Isles AF, Newth CJ. J Allergy Clin Immunol; 1985 Mar; 75(3):377-81. PubMed ID: 3973312 [Abstract] [Full Text] [Related]
18. Evaluation of a new sustained-release theophylline tablet for children. Selvig K, Alme A, Rugstad HE, Aas K, Bjerve KS. Acta Paediatr Scand; 1981 Nov; 70(6):929-33. PubMed ID: 7324949 [Abstract] [Full Text] [Related]
19. Food-induced "dose-dumping" from a once-a-day theophylline product as a cause of theophylline toxicity. Hendeles L, Weinberger M, Milavetz G, Hill M, Vaughan L. Chest; 1985 Jun; 87(6):758-65. PubMed ID: 3996063 [Abstract] [Full Text] [Related]
20. Comparison of aminophylline and theophylline sustained-release formulations by their bioavailability and steady-state serum levels. Steinijans VW, Zech K, Fischer R. Int J Clin Pharmacol Ther Toxicol; 1983 Dec; 21(12):624-30. PubMed ID: 6668100 [Abstract] [Full Text] [Related] Page: [Next] [New Search]